NCT06256393 Inflammatory Bowel Disease Cohort in Nantes
| NCT ID | NCT06256393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Inflammatory Bowel Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 360 participants |
| Start Date | 2025-02-04 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 360 participants in total. It began in 2025-02-04 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age; * Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis; * Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy; * Patients who have given written consent to participate in the study and to keep biological samples for research purposes Exclusion Criteria: * Patients refusing to participate in the cohort; * Patients with chronic inflammatory bowel disease quiescent at inclusion; * Patients with a contraindication to general anaesthesia; * Vulnerable patients (under court protection, curators, guardians);
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06256393 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inflammatory Bowel Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06256393 currently recruiting?
Yes, NCT06256393 is actively recruiting participants. Contact the research team at catherine.leberre@chu-nantes.fr for enrollment information.
Where is the NCT06256393 trial being conducted?
This trial is being conducted at Nantes, France, Nantes, France, Nantes, France.
Who is sponsoring the NCT06256393 clinical trial?
NCT06256393 is sponsored by Nantes University Hospital. The trial plans to enroll 360 participants.